Skip to main content
Jeffrey Peppercorn, MD, Oncology, Boston, MA

JeffreyMPeppercornMDMPH

Oncology Boston, MA

Associate Professor, Medicine, Harvard Medical School

Dr. Peppercorn is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Peppercorn's full profile

Already have an account?

  • Office

    55 Fruit St
    # 9A
    Boston, MA 02114
    Phone+1 617-726-6500
    Fax+1 617-724-1079

Education & Training

  • Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute
    Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2002 - 2005
  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Internal Medicine, 1998 - 2001
  • Harvard Medical School
    Harvard Medical SchoolClass of 1998

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2000 - 2025
  • NC State Medical License
    NC State Medical License 2005 - 2017
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • The individualized Goals of Care Discussion Guide: A simple tool to empower patients with metastatic breast cancer. 
    2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

  • HealthWell Foundation Launches Behavioral Health Fund to Assist COVID-19 Frontline Health Care Workers
    HealthWell Foundation Launches Behavioral Health Fund to Assist COVID-19 Frontline Health Care WorkersFebruary 10th, 2021
  • Study: Treatment of Patients in Clinical Trials Is No Better Than Average Care
    Study: Treatment of Patients in Clinical Trials Is No Better Than Average CareMay 12th, 2020
  • 'Surprising' Number of Cancer Survivors Use Alcohol
    'Surprising' Number of Cancer Survivors Use AlcoholJanuary 22nd, 2020
  • Join now to see all

Professional Memberships